Table 1 Antimicrobial susceptibility of ECB.
Antimicrobial agent | Susceptible | Intermediate | Resistant |
|---|---|---|---|
Ampicillin | 0/116 (0%) | 0/116 (0%) | 116/116 (100%) |
Ampicillin/sulbactam | 3/116 (2.6%) | 17/116 (14.7%) | 96/116 (82.8%) |
Piperacillin | 0/117 (0%) | 0/117 (0%) | 117/117 (100%) |
Piperacillin/tazobactam | 95/117 (81.2%) | 7/117 (6.0%) | 15/117 (12.8%) |
Cefuroxime | 0/116 (0%) | 1/116 (0.9%) | 115/116 (99.1%) |
Cefotaxime | 3/117 (2.6%) | 2/117 (1.7%) | 112/117 (95.7%) |
Ceftazidime | 6/117 (5.1%) | 38/1117 (32.5%) | 73/117 (62.4%) |
Aztreonam | 2/110 (1.8%) | 12/110 (10.9%) | 96/110 (87.3%) |
Imipenem | 117/117 (100%) | 0/117 (0%) | 0/117 (0%) |
Meropenem | 117/117 (100%) | 0/117 (0%) | 0/117 (0%) |
Gentamicin | 97/117 (82.9%) | 1/117 (0.9%) | 19/117 (16.2%) |
Amikacin | 114/117 (97.4%) | 3/117 (2.6%) | 0/117 (0%) |
Tobramycin | 74/107 (69.2%) | 3/107 (2.8%) | 30/107 (28.0%) |
Colistin | 116/117 (99.1%) | 0/117 (0%) | 1/117 (0.9%) |
Fosfomycin | 103/111 (92.8%) | 0/111 (0%) | 8/111 (7.2%) |
Ciprofloxacin | 28/117 (23.9%) | 2/117 (1.7%) | 87/117 (74.4%) |
Levofloxacin | 29/116 (26.7%) | 1/116 (5.2%) | 79/116 (68.1%) |
Moxifloxacin | 29/117 (24.8%) | 1/117 (0.9%) | 87/117 (74.4%) |
Cotrimoxazol | 46/117 (39.3%) | 2/117 (1.7%) | 69/117 (59.0%) |
Tigecycline | 62/63 (98.4%) | 0/63 (0%) | 1/63 (1.6%) |
